Stoke Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Bedford, MA
STOK chart
What traders are saying about $STOK
Latest postsStoke Therapeutics, Inc. news
- Weekly Recap: EMPEROR enrollment complete and Q3 revenue up, loss widens
TradingView ·
- How Wider Losses At Stoke Therapeutics (STOK) Have Changed Its Investment Story
Simply Wall St ·
- Stoke Therapeutics (STOK) Faces A Valuation Test Following Weaker Nine Month Results
Yahoo Finance ·
- Stoke Therapeutics Stock Price Forecast. Should You Buy STOK?
StockInvest.us ·
- Is Stoke Therapeutics (STOK) Undervalued After Its Latest Earnings Losses?
Simply Wall St ·
- Stoke Therapeutics Inc (0GT.MU) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- One Stoke Therapeutics (STOK) holder reports 4.82 million shares but zero voting power.
Stock Titan ·
- Stoke Therapeutics (NASDAQ:STOK) Stock Crosses Above Fifty Day Moving Average - Should You Sell?
MarketBeat ·
- Stoke Therapeutics, Inc. (0GT.F) Seasonal returns chart
Yahoo Finance UK ·
- Stoke Therapeutics (STOK) Chief Medical Officer Barry Ticho Sells 7,195 Shares
GuruFocus ·
- Stoke Therapeutics 3Q 2026: Revenue $11.3M, Net loss $73.6M, EPS $(1.08) — 10-Q Summary
TradingView ·
- Stoke Therapeutics, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:STOK) 2026-11-03
Seeking Alpha ·
Stoke Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $184.4M | $36.6M | $8.8M | $12.4M |
| Net income | -$6.9M | -$89.0M | -$104.7M | -$101.1M |
| Diluted EPS | $-0.12 | $-1.65 | $-2.38 | $-2.60 |
| Total assets (year end) | $418.4M | $271.6M | $228.3M | $256.1M |
| Cash and equivalents (year end) | $84.2M | $128.0M | $191.4M | $113.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Stoke Therapeutics, Inc.
- Ticker
- STOK (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bedford, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1623526
- Former names
- ASOthera Pharmaceuticals, Inc.
Frequently asked questions
What exchange is Stoke Therapeutics, Inc. listed on?
Stoke Therapeutics, Inc. trades on the Nasdaq under the ticker symbol STOK.
What industry is Stoke Therapeutics, Inc. in?
Stoke Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Stoke Therapeutics, Inc. headquartered?
Stoke Therapeutics, Inc.'s business address on file with the SEC is in Bedford, MA.
When does Stoke Therapeutics, Inc.'s fiscal year end?
Stoke Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Stoke Therapeutics, Inc. report?
Stoke Therapeutics, Inc. reported $184.4M in revenue for calendar year 2025, according to its SEC filings.